2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Mohamed AI et al. In-vivo evaluation of clindamycin release from glyceryl monooleate-alginate microspheres by NIR spectroscopy. 2015 Int J Pharm pmid:26276253
Gonçalves VSS et al. Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles. 2015 Int J Pharm pmid:26277371
Pham AC et al. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. 2015 Drug Deliv Transl Res pmid:26328930
Lopes I et al. Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells. 2016 J Liposome Res pmid:26340109
Rosa A et al. Monoolein-based cubosomes affect lipid profile in HeLa cells. 2015 Chem. Phys. Lipids pmid:26341749
Peng X et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. 2015 Drug Des Devel Ther pmid:26345516
Elnaggar YS et al. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies. 2015 Int J Nanomedicine pmid:26346130
Wibroe PP et al. Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers. 2015 Nanomedicine pmid:26348655
Kolev V et al. Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme. 2016 Eur. Biophys. J. pmid:26424533
Li JC et al. Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol. 2015 Med. Sci. Monit. pmid:26517086
Pluhackova K et al. Extension of the LOPLS-AA Force Field for Alcohols, Esters, and Monoolein Bilayers and its Validation by Neutron Scattering Experiments. 2015 J Phys Chem B pmid:26537654
Zawalich WS et al. The conditions under which rat islets are labelled with [3H]inositol alter the subsequent responses of these islets to a high glucose concentration. 1989 Biochem. J. pmid:2658979
Patil SS et al. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. 2016 Drug Dev Ind Pharm pmid:26651381
Rossetti FC et al. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. 2016 Eur J Pharm Sci pmid:26657201
Shi X et al. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo. 2017 Pharm Dev Technol pmid:26670780
Zawalich WS et al. The effect of monooleoylglycerol on insulin secretion from isolated perifused rat islets. 1989 Diabetologia pmid:2668083
Mazzoni S et al. Cytochrome-c Affects the Monoolein Polymorphism: Consequences for Stability and Loading Efficiency of Drug Delivery Systems. 2016 Langmuir pmid:26710233
Oka T et al. Activation Energy of the Low-pH-Induced Lamellar to Bicontinuous Cubic Phase Transition in Dioleoylphosphatidylserine/Monoolein. 2016 Langmuir pmid:26766583
Ruela AL et al. Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment. 2016 J Pharm Sci pmid:26852841
Tsoneva IC Electric field-induced fusion of yeast protoplasts. The role of different physical and chemical factors. 1989 Acta Microbiol Bulg pmid:2696336